Devices and methods for encapsulating a portion of a wound dressing with biocompatible coating are disclosed. In some embodiments, a method includes applying a first coating on a first side of a flexible substrate of the wound dressing. The first side of the substrate can support a plurality of electronic components, electronic tracks, and connectors between the electronic components and electronic tracks. The first coating can be applied to at least one connectors. The application of the first coating can strengthen the at least one connector. The method can further include applying a second biocompatible coating on the first side of the substrate of the wound dressing and coating a second side of the substrate opposite the first side with a third coating, and coating at least some of the plurality of the electronic components with a fourth coating.

A handheld portable electrostatic device for electrostatically applying a treatment solution to a treatment site of a patient, including a housing and a cartridge removably disposed in the housing. The cartridge includes a cartridge housing and a nozzle for applying the treatment solution. An electrostatic module is provided to electrostatically charge and ionize molecules of the treatment solution of the cartridge. The treatment solution is configured to flow toward the nozzle whereby at least one electrode electrically connected to the electrostatic module physically contacts the treatment solution as it flows therethrough and applies an electrical charge to the treatment solution.

A method of preparing an occlusive wound dressing involves preparing a slurry of an occlusive composition with a hydrophobic compound and a bacteriostatic agent, applying the occlusive composition on a fabric to produce a coated fabric, disposing the coated fabric in packaging, adding water onto at least one of the coated fabric and the packaging, sealing the packaging containing the coated fabric, and irradiating the sealed package to sterilize and produce the occlusive wound dressing. The occlusive wound dressing has from about 60 wt % to about 75 wt % hydrophobic compound, from about 2 wt % to about 5 wt % bacteriostatic agent, from about 2 wt % to about 5 wt % water, and from about 5 wt % to about 36 wt % fabric.

An applicator is disclosed for applying a treatment solution to a treatment site of a patient. The applicator can include an applicator housing comprising a treatment solution reservoir. A cartridge can be removably disposed in the housing. The cartridge when arranged in the housing can be in fluid communication with the treatment solution reservoir. The cartridge can include an electrostatic module for electrostatically charging the treatment solution in the treatment solution reservoir; and a nozzle for applying the treatment solution.

A medical dressing material having a chitosan fabric sponge structure according to the present disclosure has a structure in which chitosan fibers derived from a chitosan fabric are located on a porous structure formed using freeze-drying. Therefore, the medical dressing material has an excellent hemostatic effect and exudate-absorbing ability while exhibiting a strong tensile force, is convenient to use, and is capable of being molded into various forms so as to be widely used for wounds by an edged thing, scalds, pressure ulcers, diabetes-related foot disorders, or various surgical areas in various body tissue parts such as the spine, brain, eye, ear, nose, and cervix.

The present disclosure relates to a dermal drug delivery platform comprising: a primary wound dressing comprising three-dimensional polymer protuberances that extend upward from the dressing surface to engage the wound. The protuberances comprise at least one biocompatible and/or biodegradable polymer and medicinal nanoparticles. In one embodiment, the medicinal nanoparticles may be metallic and provide surface-area-enhanced galvanic action to drive medicinal ions into the wound bed. Various methods of making the disclosed dermal drug delivery platform, as well as three-dimensional methods of treating a wound using the platform are also disclosed.

A decorative splint material includes a moisture-curable material adapted to be wetted and molded into a splint configuration that conforms to an anatomical body part. The material hardens via a curing process to retain the splint configuration. The splint material includes a plurality of decorative elements integrated with the splint material. The decorative elements are provided on a substrate which is overlaid onto the moisture-curable material, and the substrate is overlaid with a flexible sheet having a plurality of openings which align with the decorative elements. The decorative elements are retained by the sheet of splint material when the sheet is wetted, molded into a splint configuration, and hardened.

Disclosed is a wound dressing material comprising a substrate, about 2.5% to about 8% by weight of a bicarbonate, and a film-forming agent, the film-forming agent serving as a binder for said bicarbonate to said substrate, the film-forming agent and the bicarbonate being present in a ratio of between 1:2 and 2:1 with respect to one another. Also disclosed are a method for preparing a wound dressing material and a method for treating a wound.

A wound dressing, including fibers containing silver ions. The fibers are manufactured by dissolving silver nitrate into a polymer solution in the substantial absence of light, and then extruding the obtained solution into fibers by wet spinning process. The silver content of the wound dressing is between 0.01-10% by weight, and preferably 0.1-7% by weight.

Foam wound inserts with high-density and low-density regions, methods for making wound inserts, wound-treatment methods, and wound-treatment systems.